A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG study
一项随机II/III期研究，比较紫杉醇/卡铂/二甲双胍与紫杉醇/卡铂/安慰剂作为可测量III期或IVA期、IVB期或复发性子宫内膜癌初始治疗方案的疗效：NRG肿瘤学/GOG研究
期刊:Gynecologic Oncology
影响因子:4.5
doi:10.1016/j.ygyno.2025.03.003
Victoria L Bae-Jump ,Michael W Sill ,Paola A Gehrig ,Jason D Merker ,David L Corcoran ,Adam D Pfefferle ,Michele C Hayward ,Joan L Walker ,Andrea R Hagemann ,Steven E Waggoner ,Roisin E O'Cearbhaill ,Megan E McDonald ,Mitchell I Edelson ,Paul A DiSilvestro ,Amy L McNally ,Aimee Fleury ,Ramey D Littell ,Frederick R Ueland ,Heather A Lankes ,Carol Aghajanian
